Page 15

TACKLING INFECTIOUS DISEASES

Aspen is committed to playing a meaningful role in tackling infectious diseases. Aspen is an established leader in the provision of generic ARVs to HIV/AIDS patients throughout Africa, covering some 300 000 lives. Aspen is set to add to its already extensive ARV product offering with a range of new products currently in development. The Group is pursuing new initiatives which will allow it to offer treatment for tuberculosis as well as multi-drug resistant tuberculosis. Each year more than eight million new tuberculosis cases are diagnosed globally.

11

Aspen Annual Report 2006

Profile for Aspen Holdings

Aspen Annual Report 2006  

Aspen Annual Report 2006